# [11C]Acetate PET in Patients With Glioma

> **NCT02986815** · NA · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Glioma

## Interventions

- **OTHER:** [11C]Acetate Brain Imaging

## Key facts

- **NCT ID:** NCT02986815
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-24
- **Primary completion:** 2020-05-05
- **Final completion:** 2020-05-05
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2021-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02986815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02986815, "[11C]Acetate PET in Patients With Glioma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02986815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
